Latest Research And Development News

Smart Parking Limited has reported a robust half-year performance with a 20% increase in revenue and a 70% rise in net profit, driven by international expansion and operational growth across multiple markets.

Audinate delivered 1H25 results above guidance despite a transitional year marked by inventory adjustments, with software revenue growth and strategic product launches setting the stage for a return to growth in FY26.

AVITA Medical reported a strong 30% increase in Q4 2024 commercial revenue and amended its credit agreement with OrbiMed to adjust revenue covenants through 2026. The company is poised for significant growth with new product rollouts and expects profitability by year-end 2025.

AVITA Medical reported a robust 30% increase in Q4 2024 commercial revenue alongside key FDA clearances, setting the stage for ambitious growth in 2025.

Cochlear Limited posted a 6% increase in HY25 sales revenue driven by strong implant sales but anticipates FY25 profits at the lower end of guidance due to declining services revenue and rising cloud investments.

Cochlear Limited has reported a robust half-year performance with a 7% increase in underlying net profit and an 8% rise in interim dividends, driven by strong sales in cochlear and acoustic implants despite a decline in services revenue.

Archer Materials has successfully detected spin states in its carbon-based quantum material using a novel resonator design, marking a pivotal step toward functional qubit development for quantum computing.

Pro Medicus Limited delivered a robust half-year performance ending December 2024, with after-tax profits soaring 42.7% to $51.74 million and revenues climbing 31.1% to $97.2 million, driven by significant contract wins in North America and sustained growth in Australia.

Cycliq Group Limited reported an 18% revenue increase to $2.9 million for the half-year ending December 2024, driven by higher transaction values and a revamped marketing strategy, despite a modest net loss of $211,214.

Echo IQ has secured a $1.26 million refund under the Australian Government's R&D Tax Incentive, reinforcing its commitment to AI-driven solutions for structural heart disease detection.

IMDEX Limited reported a significant 84% increase in net profit for the half-year ended December 31, 2024, even as revenue declined by 10%. The company declared a steady interim dividend, underscoring confidence amid mixed financial signals.

Argenica Therapeutics reported a 16% reduction in half-year losses to $1.19 million, buoyed by a 29% increase in other income largely from R&D tax incentives, as it advances its neuroprotective drug development.